SEARCH

SEARCH BY CITATION

References

  • 1
    O'Brien M, Manches O, Sabado RL et al. Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-α-producing and partially matured phenotype. J Clin Invest 2011; 121:1088101.
  • 2
    Sabado RL, O'Brien M, Subedi A et al. Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 2010; 116:383952.
  • 3
    Favre D, Lederer S, Kanwar B et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 2009; 5:e1000295.
  • 4
    Favre D, Mold J, Hunt PW et al. Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Sci Transl Med 2010; 2:32ra36.
  • 5
    Reeves RK, Rajakumar PA, Evans TI et al. Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection. Blood 2011; 118:332130.
  • 6
    Reeves RK, Evans TI, Gillis J, Wong FE, Kang G, Li Q, Johnson RP. SIV infection induces accumulation of plasmacytoid dendritic cells in the gut mucosa. J Infect Dis 2012; 206:14628.
  • 7
    Bosinger SE, Sodora DL, Silvestri G. Generalized immune activation and innate immune responses in simian immunodeficiency virus infection. Curr Opin HIV AIDS 2011; 6:4118.
  • 8
    Brenchley JM, Price DA, Schacker TW et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:136571.
  • 9
    Estes JD, Harris LD, Klatt NR et al. Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections. PLoS Pathog 2010; 6:e1001052.
  • 10
    Fitzgerald-Bocarsly P, Jacobs ES. Plasmacytoid dendritic cells in HIV infection: striking a delicate balance. J Leukoc Biol 2010; 87:60920.
  • 11
    Chehimi J, Campbell DE, Azzoni L et al. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J Immunol 2002; 168:4796801.
  • 12
    Lepelley A, Louis S, Sourisseau M et al. Innate sensing of HIV-infected cells. PLoS Pathog 2011; 7:e1001284.
  • 13
    Reeves RK, Fultz PN. Disparate effects of acute and chronic infection with SIVmac239 or SHIV-89.6P on macaque plasmacytoid dendritic cells. Virology 2007; 365:35668.
  • 14
    Brown KN, Trichel A, Barratt-Boyes SM. Parallel loss of myeloid and plasmacytoid dendritic cells from blood and lymphoid tissue in simian AIDS. J Immunol 2007; 178:695867.
  • 15
    Malleret B, Karisson I, Maneglier B et al. Effect of SIVmac infection on plasmacytoid and CD1c+ myeloid dendritic cells in cynomolgus macaques. Immunology 2008; 124:22333.
  • 16
    Diop OM, Ploquin MJ, Mortara L et al. Plasmacytoid dendritic cell dynamics and α interferon production during simian immunodeficiency virus infection with a nonpathogenic outcome. J Virol 2008; 82:514552.
  • 17
    Kwa S, Kannanganat S, Nigam P et al. Plasmacytoid dendritic cells are recruited to the colorectum and contribute to immune activation during pathogenic SIV infection in rhesus macaques. Blood 2011; 118:276373.
  • 18
    Brown KN, Wijewardana V, Liu X, Barratt-Boyes SM. Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection. PLoS Pathog 2009; 5:e1000413.
  • 19
    Donaghy H, Gazzard B, Gotch F, Patterson S. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 2003; 101:450511.
  • 20
    Patterson S, Rae A, Hockey N, Gilmour J, Gotch F. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J Virol 2001; 75:67103.
  • 21
    Schmidt B, Scott I, Whitmore RG, Foster H, Fujimura S, Schmitz J, Levy JA. Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation. Virology 2004; 329:2808.
  • 22
    Smed-Sorensen A, Lore K, Vasudevan J, Louder MK, Andersson J, Mascola JR, Spetz AL, Koup RA. Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J Virol 2005; 79:88619.
  • 23
    Reeves RK, Evans TI, Gillis J, Wong FE, Connole M, Carville A, Johnson RP Quantification of mucosal mononuclear cells in tissues with a fluorescent bead-based polychromatic flow cytometry assay. J Immunol Methods 2011; 367:958.
  • 24
    Reeves RK, Gillis J, Wong FE, Yu Y, Connole M, Johnson RP et al. CD16 natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infection. Blood 2010; 115:443946.
  • 25
    Roederer M, Nozzi JL, Nason MC. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 2011; 79A:16774.
  • 26
    Cline AN, Bess JW, Piatak M Jr, Lifson JD. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J Med Primatol 2005; 34:30312.
  • 27
    Tilton JC, Manion MM, Luskin MR et al. Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished α interferon production in vitro. J Virol 2008; 82:39974006.
  • 28
    Conry SJ, Milkovich KA, Yonkers NL et al. Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function. J Virol 2009; 83:1117587.
  • 29
    Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends Microbiol 2013; 21:613.
  • 30
    Byrnes M, Travers K, Burns M, Sapra S. A systematic literature review examining soluble and cellular biomarkers in HIV patients receiving antiretroviral therapy. J Int AIDS Soc 2012; 15:18172.
  • 31
    Reiss P. HIV, co-morbidity and ageing. J Int AIDS Soc 2012; 15(Suppl. 4):18073.
  • 32
    Jiang W, Ledermann M, Hunt P et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis 2009; 199:117785.
  • 33
    Boasso A, Herbeuval JP, Hardy AW, Anderson SA, Dolan MJ, Fuchs D, Shearer GM. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells. Blood 2007; 109:33519.
  • 34
    Chang JJ, Altfeld M. Innate immune activation in primary HIV-1 infection. J Infect Dis 2010; 202(Suppl. 2):S297301.
  • 35
    Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 2006; 107:26138.
  • 36
    Gasper-Smith N, Crossman DM, Whitesides JF et al. Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design. J Virol 2008; 82:770010.
  • 37
    Schiller M, Parcina M, Heyder P et al. Induction of type I IFN is a physiological immune reaction to apoptotic cell-derived membrane microparticles. J Immunol 2012; 189:174756.